
Nrx Pharmaceuticals Inc. (NASDAQ: NRXP) Subsidiary To Acquire 49% Stake In Prominent Florida Neuropsychiatry Clinic
(MENAFN- Investor Brand Network) The acquisition of Cohen and Associates, a respected interventional psychiatry practice, by NRx subsidiary HOPE Therapeutics, is expected to be immediately accretive to revenue and EBITDA. Cohen, serving the Sarasota- …